Safety and how the body processes AD-230 in healthy adults
Part of Digestive system, Hormones & metabolism clinical trials.
This study tests a new drug called AD-230 to understand how your body absorbs and processes it, and whether food affects this process. You'll be a healthy volunteer helping researchers gather safety information.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age between 19 and 64 years old
- Body mass index (BMI) between 18.5 and 29.9 (roughly average weight for your height)
- In good general health with no serious medical conditions
- Not currently enrolled in another drug study
- Haven't participated in another clinical drug trial in the past 6 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-stage trial tests how a new drug called AD-230 moves through the body and whether it's safe in healthy volunteers. Researchers will measure drug levels in your blood and watch for any side effects.
This study tests how two experimental drugs, called AD-236A and AD-236B, interact in the body and checks if they are safe. Healthy volunteers are needed to see how the drugs affect each other.
This early-stage study tests a new investigational drug called AD-231 to see how safe it is and how your body processes it. Researchers will compare it to a combination of three related drugs to understand which approach works best.
This trial tests three similar drugs to see how they are processed by the body and how safe they are. It is for healthy volunteers to help find the best dose and form of these medications.
This trial tests whether three experimental drugs (AD-231A, AD-231B, and AD-231C) interact with each other and how safe they are. Healthy volunteers are needed to help understand how the body processes these drugs.
This early-stage study tests a new medicine called AD-123 and compares how the body processes it versus two other medicines given together. Researchers will monitor your health and measure drug levels in your blood to make sure it's safe.
Hear when a new Chronic Liver Disease (CLD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.